BRCA1 and ovarian cancer: Germline genetic testing in women diagnosed with EOC demonstrated that ~ 13.5% carry a pathogenic variant (PV) that increases ovarian cancer risk; ~11% in BRCA1/2 and ~ 2.5% in other moderate penetrant genes such as RAD51C/D, BRIP1, and PALB2 [9].